Birmingham Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28,681
Closed -$498K 103
2023
Q3
$498K Buy
28,681
+7,740
+37% +$161K 0.21% 77
2023
Q2
$436K Sell
20,941
-3,685
-15% -$80.1K 0.18% 84
2023
Q1
$579K Hold
24,626
0.23% 76
2022
Q4
$688K Buy
24,626
+2,623
+12% +$67.1K 0.26% 71
2022
Q3
$515K Sell
22,003
-812
-4% -$24.5K 0.23% 79
2022
Q2
$770K Sell
22,815
-960
-4% -$33.6K 0.31% 61
2022
Q1
$830K Sell
23,775
-805
-3% -$27.5K 0.29% 64
2021
Q4
$748K Buy
24,580
+11,357
+86% +$370K 0.27% 75
2021
Q3
$434K Buy
13,223
+3,288
+33% +$105K 0.17% 85
2021
Q2
$301K Buy
+9,935
New +$327K 0.11% 92

Other funds holding OGN

Birmingham Capital Management's OGN Position: Q4 2023 in Review

Birmingham Capital Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 28,681 shares — an estimated $498K sold.

Birmingham Capital Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $830K in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Birmingham Capital Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Birmingham Capital Management sold 28,681 Organon & Co shares in Q4 2023, an estimated $498K.
  • Birmingham Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Birmingham Capital Management's Organon & Co position peaked at $830K in Q1 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Birmingham Capital Management's 13F filing for Q4 2023, filed 20 Feb 2024.